Cargando…

Plasma xanthine oxidoreductase activity in Japanese patients with type 2 diabetes across hospitalized treatment

AIMS/INTRODUCTION: Xanthine oxidoreductase (XOR) is an enzyme that catalyzes hypoxanthine and xanthine to xanthine and uric acid, respectively. Plasma XOR activity has recently been measured in humans. However, limited information is known about plasma XOR activity in patients with type 2 diabetes m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kawachi, Yusuke, Fujishima, Yuya, Nishizawa, Hitoshi, Nagao, Hirofumi, Nakamura, Takashi, Akari, Seigo, Murase, Takayo, Taya, Naohiro, Omori, Kazuo, Miyake, Akimitsu, Fukuda, Shiro, Takahara, Mitsuyoshi, Kita, Shunbun, Katakami, Naoto, Maeda, Norikazu, Shimomura, Iichiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8354500/ https://www.ncbi.nlm.nih.gov/pubmed/33211396 http://dx.doi.org/10.1111/jdi.13467

Ejemplares similares

The Effects of Topiroxostat, a Selective Xanthine Oxidoreductase Inhibitor, on Arterial Stiffness in Hyperuricemic Patients with Liver Dysfunction: A Sub-Analysis of the BEYOND-UA Study
por: Fujishima, Yuya, et al.
Publicado: (2023)

Increased plasma XOR activity induced by NAFLD/NASH and its possible involvement in vascular neointimal proliferation
por: Kawachi, Yusuke, et al.
Publicado: (2021)

Influence of xanthine oxidoreductase inhibitor, topiroxostat, on body weight of diabetic obese mice
por: Nakamura, Takashi, et al.
Publicado: (2021)

Systemic Endothelial Function, Plasma Xanthine Oxidoreductase Activity, and Blood Pressure Variability in Patients with Stable Coronary Artery Disease
por: Hiraga, Takashi, et al.
Publicado: (2022)

Possible role of insulin resistance in activation of plasma xanthine oxidoreductase in health check-up examinees
por: Kurajoh, Masafumi, et al.
Publicado: (2022)

Association between plasma xanthine oxidoreductase activity and in-hospital outcomes in patients with stable coronary artery disease after percutaneous coronary intervention
por: Sato, Ryota, et al.
Publicado: (2021)

Associations of circulating xanthine oxidoreductase activity with cardiometabolic risk markers in overweight and obese Japanese men: a cross-sectional pilot study
por: Kosaki, Keisei, et al.
Publicado: (2022)

Xanthine oxidoreductase activity is correlated with hepatic steatosis
por: Yagi, Chisako, et al.
Publicado: (2022)

Time-Series Change of Serum Soluble T-Cadherin Concentrations and Its Association with Creatine Kinase-MB Levels in ST-Segment Elevation Myocardial Infarction
por: Iioka, Masahito, et al.
Publicado: (2022)

Association of plasma xanthine oxidoreductase activity with vascular endothelial function independent of serum uric acid level: MedCity21 health examination registry
por: Kurajoh, Masafumi, et al.
Publicado: (2023)

Uric acid shown to contribute to increased oxidative stress level independent of xanthine oxidoreductase activity in MedCity21 health examination registry
por: Kurajoh, Masafumi, et al.
Publicado: (2021)

Independent links between plasma xanthine oxidoreductase activity and levels of adipokines
por: Furuhashi, Masato, et al.
Publicado: (2019)

Native adiponectin in serum binds to mammalian cells expressing T-cadherin, but not AdipoRs or calreticulin
por: Kita, Shunbun, et al.
Publicado: (2019)

Plasma metabolites associated with arterial stiffness in patients with type 2 diabetes
por: Katakami, Naoto, et al.
Publicado: (2020)

Gender Differences in the Impact of Plasma Xanthine Oxidoreductase Activity on Coronary Artery Spasm
por: Watanabe, Ken, et al.
Publicado: (2021)

Comparison of continuous subcutaneous insulin infusion treatment and multiple daily injection treatment on the progression of diabetic complications in Japanese patients with juvenile‐onset type 1 diabetes mellitus
por: Masuda, Takafumi, et al.
Publicado: (2022)

Diurnal Variations in Serum Uric Acid, Xanthine, and Xanthine Oxidoreductase Activity in Male Patients with Coronary Artery Disease
por: Shimizu, Megumi, et al.
Publicado: (2023)

Plasma Xanthine Oxidoreductase (XOR) Activity in Cardiovascular Disease Outpatients
por: Matsushita, Masato, et al.
Publicado: (2020)

Habitual exercise decreases plasma xanthine oxidoreductase activity in middle-aged and older women
por: Kosaki, Keisei, et al.
Publicado: (2018)

Xanthine oxidoreductase activity is associated with serum uric acid and glycemic control in hemodialysis patients
por: Nakatani, Ayumi, et al.
Publicado: (2017)

Impact of plasma xanthine oxidoreductase activity in patients with heart failure with preserved ejection fraction
por: Watanabe, Ken, et al.
Publicado: (2020)

Evaluation of change in metabolome caused by comprehensive diabetes treatment: A prospective observational study of diabetes inpatients with gas chromatography/mass spectrometry‐based non‐target metabolomic analysis
por: Taya, Naohiro, et al.
Publicado: (2021)

Relationship between Xanthine Oxidoreductase Redox and Oxidative Stress among Chronic Kidney Disease Patients
por: Terawaki, Hiroyuki, et al.
Publicado: (2018)

Association of the plasma xanthine oxidoreductase activity with the metabolic parameters and vascular complications in patients with type 2 diabetes
por: Okuyama, Tomoko, et al.
Publicado: (2021)

Extracellular Vesicles as an Endocrine Mechanism Connecting Distant Cells
por: Kita, Shunbun, et al.
Publicado: (2022)

Risk categorization for calculating net reclassification improvement
por: Takahara, Mitsuyoshi, et al.
Publicado: (2013)

Changes of HbA1c variability after the switch to a longer‐acting insulin analog in people with type 1 diabetes
por: Watanabe, Hirotaka, et al.
Publicado: (2022)

Change in fatty acid composition of plasma triglyceride caused by a 2 week comprehensive risk management for diabetes: A prospective observational study of type 2 diabetes patients with supercritical fluid chromatography/mass spectrometry‐based semi‐target lipidomic analysis
por: Taya, Naohiro, et al.
Publicado: (2022)

Time‐dependent changes in plasma xanthine oxidoreductase during hospitalization of acute heart failure
por: Okazaki, Hirotake, et al.
Publicado: (2020)

Identification and Clinical Associations of 3 Forms of Circulating T-cadherin in Human Serum
por: Fukuda, Shiro, et al.
Publicado: (2021)

Adiponectin accumulation in the retinal vascular endothelium and its possible role in preventing early diabetic microvascular damage
por: Sakaue, Taka-aki, et al.
Publicado: (2022)

A Newly Developed Method-Based Xanthine Oxidoreductase Activities in Various Human Liver Diseases
por: Sato, Ken, et al.
Publicado: (2023)

Relationship between plasma xanthine oxidoreductase activity and left ventricular ejection fraction and hypertrophy among cardiac patients
por: Fujimura, Yuki, et al.
Publicado: (2017)

Plasma xanthine oxidoreductase activity in patients with decompensated acute heart failure requiring intensive care
por: Okazaki, Hirotake, et al.
Publicado: (2019)

Impact of Plasma Xanthine Oxidoreductase Activity on the Mechanisms of Distal Symmetric Polyneuropathy Development in Patients with Type 2 Diabetes
por: Fujishiro, Midori, et al.
Publicado: (2021)

Distribution of the Matsuda Index in Japanese healthy subjects
por: Takahara, Mitsuyoshi, et al.
Publicado: (2013)

Association between poor psychosocial conditions and diabetic nephropathy in Japanese type 2 diabetes patients: A cross‐sectional study
por: Ninomiya, Hiroyo, et al.
Publicado: (2017)

Association of plasma xanthine oxidoreductase activity with blood pressure affected by oxidative stress level: MedCity21 health examination registry
por: Yoshida, Shio, et al.
Publicado: (2020)

ER stress decreases exosome production through adiponectin/T-cadherin-dependent and -independent pathways
por: Fukuoka, Keita, et al.
Publicado: (2023)

Human adipose-derived mesenchymal stem cells prevent type 1 diabetes induced by immune checkpoint blockade
por: Kawada-Horitani, Emi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_21n9e5njpdaqvgtpeu02q1ptee